Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Fella Health vs Wisp

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.1

Fella Health

Best for men's weight loss
★★★3.6

Starting at $165/mo

CompoundedSemaglutideTirzepatideBuilt for Men
Visit Fella Health
7.0

Wisp

Best for buyers who want a board-certified telehealth platform offering both branded injectables AND a sublingual alternative — with full disclosure that the sublingual form is not human-tested
★★★3.5

Starting at $225/mo

Brand WegovyBrand ZepboundBrand SaxendaCompounded Sublingual Semaglutide
Visit Wisp

Side-by-Side Comparison

FeatureFella HealthWisp
Overall Score7.1/107.0/10
Starting Price$165/mo$225/mo
Editorial Rating3.6 ★ /53.5 ★ /5
Features8 features6 features
States Available200
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Fella Health

Pros

  • Specialized vertical — program designed for men, particularly 'bigger guys'
  • Free 1:1 health coaching included with the membership
  • 6-month money-back guarantee if the program doesn't work
  • Flat monthly price stays the same as your dose escalates
  • Both compounded semaglutide and tirzepatide available
  • Discloses partner pharmacies (Strive Pharmacy in AZ, Red Rock Home Pharmacy in UT)

Cons

  • Limited to men's health vertical — not available to women
  • Available in only 20 published states (not nationwide)
  • Exact GLP-1 monthly cost not published on the public site — only an 'under $10/day' starting figure
  • Pricing transparency below industry standard for compounded GLP-1 telehealth

Wisp

Pros

  • Wider GLP-1 menu than the prior stub suggested — both branded injectables (Wegovy, Zepbound, Saxenda) AND the compounded sublingual option
  • LegitScript certified, board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC publicly named)
  • Wisp's product page uses appropriately cautious language around sublingual: 'lab tests using human-derived tissues suggest it may begin working' and 'effectiveness in patients may vary' — disclosure is more rigorous than most compounded GLP-1 marketing

Cons

  • EFFECTIVENESS CAVEAT: sublingual compounded semaglutide has not been tested in humans — Wisp's own product page explicitly states this. Injectables (Wegovy, Zepbound, Saxenda) on the same platform have FDA safety/efficacy data; sublingual does not.
  • Pharmacy partners not publicly named
  • States served list not publicly enumerated

Our Verdict

Winner: Fella HealthScore: 7.1/10

Fella Health edges out Wisp with a higher overall score of 7.1/10 and is particularly strong for men's weight loss. Wisp remains a solid alternative, especially if you're looking for buyers who want a board-certified telehealth platform offering both branded injectables AND a sublingual alternative — with full disclosure that the sublingual form is not human-tested.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.